Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Patient Preference × pazopanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 8 Sarcoma 4 Neoplasms 2 Neoplasm Metastasis 2 Patient Preference 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Kidney Neoplasms 1 Hemangiosarcoma 1 Fallopian Tube Neoplasms 1

Interventions

pertuzumab 1 pazopanib 1 enzalutamide 1 decitabine and cedazuridine drug combination 1 apalutamide 1 Trastuzumab 1 Surgical Procedures, Operative 1 Sunitinib 1 Radiotherapy 1 Injections, Subcutaneous 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01064310 2017-04-17

PISCES

Novartis

Phase 3 Completed

169 enrolled 16 charts

Carcinoma, Renal Cell, Neoplasms, Patient Preference

Data powered by HemOnc (CC BY 4.0) Colophon ⚡